The authors reply: KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease

M. Luiza Caramori, Katherine R. Tuttle, Nikhil Tandon, David J. Tunnicliffe, Ian H. de Boer, Peter Rossing, Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group, Jonathan C. Craig

Research output: Contribution to journalLetterpeer-review

Abstract

The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Work Group1 agrees with the statement by Fonseca et al.2 that hemoglobin A1c (HbA1c) may be unreliable in advanced chronic kidney disease (CKD). In addition to hyperglycemia, patients with advanced CKD are at an increased risk of hypoglycemia, and measures that more precisely reflect blood glucose levels are needed.
Original languageEnglish
Pages (from-to)420-421
Number of pages2
JournalKidney International
Volume101
Issue number2
DOIs
Publication statusPublished - Feb 2022

Keywords

  • glycemic control
  • chronic kidney disease
  • Hemoglobin A1c
  • Albumin
  • Prognostic studies

Fingerprint

Dive into the research topics of 'The authors reply: KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease'. Together they form a unique fingerprint.

Cite this